Latest Staphylococcus aureus Stories
- Treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults - DUBLIN, March 2, 2015 /PRNewswire/-- Actavis plc (NYSE: ACT) today announced that
-- Phase 1 Studies Confirm Superior Safety Profile of MRX-I Over Zyvox® -- HAYWARD, Calif. and SHANGHAI, Feb.
Trial also demonstrates strong trends in secondary clinical endpoints AUSTIN, Texas, Feb.
- Proposed label expansion would support use of TEFLARO in cases of acute bacterial skin and skin structure infections (ABSSSI) with concurrent bacteremia - DUBLIN, Feb.
New test detects MRSA and SA, the leading causes of healthcare-associated infections worldwide PLEASANTON, Calif., Jan.
- Fully human mAb neutralizes multiple virulence factors of S. aureus, including alpha-hemolysin LEBANON, N.H. and VIENNA, Jan.
GLASGOW, Scotland, January 12, 2015 /PRNewswire/ -- Highlights - In September 2014, MGB Biopharma secured GBP4M ($6.4M) from leading
Fat cells located beneath a person’s skin could help protect them from bacterial infections, according to a new study published Thursday in the journal Science.
Microbial succession in a sterilized restroom begins with bacteria from the gut and the vagina, and is followed shortly by microbes from the skin.
Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...
- In medieval musical notation, a sign or neume denoting a shake or trill.